81 related articles for article (PubMed ID: 8879625)
1. Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS).
Martín-Henao GA; Inglés-Esteve J; Cancelas JA; García J
Bone Marrow Transplant; 1996 Sep; 18(3):603-9. PubMed ID: 8879625
[TBL] [Abstract][Full Text] [Related]
2. Thy-1 (CDw90) and c-kit receptor (CD117) expression on CD34+ hematopoietic progenitor cells: a five dimensional flow cytometric study.
D'Arena G; Musto P; Cascavilla N; Carotenuto M
Haematologica; 1998 Jul; 83(7):587-92. PubMed ID: 9718862
[TBL] [Abstract][Full Text] [Related]
3. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
[TBL] [Abstract][Full Text] [Related]
4. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
5. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
[TBL] [Abstract][Full Text] [Related]
6. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
Kronenwett R; Butterweck U; Steidl U; Kliszewski S; Neumann F; Bork S; Blanco ED; Roes N; Gräf T; Brors B; Eils R; Maercker C; Kobbe G; Gattermann N; Haas R
Oncogene; 2005 Aug; 24(34):5313-24. PubMed ID: 15806158
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting.
Kato K; Radbruch A
Cytometry; 1993; 14(4):384-92. PubMed ID: 7685679
[TBL] [Abstract][Full Text] [Related]
8. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
de Wynter EA; Nadali G; Coutinho LH; Testa NG
Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
10. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
12. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
13. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
[TBL] [Abstract][Full Text] [Related]
14. CD34-positive cell selection by immunomagnetic beads and chymopapain.
Silvestri F; Banavali S; Yin M; Gopal V; Savignano C; Baccarani M; Preisler HD
Haematologica; 1992; 77(4):307-10. PubMed ID: 1385276
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
[TBL] [Abstract][Full Text] [Related]
18. Expression of differentiation antigens and adhesion molecules on CD34+ cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony stimulating factor.
Masauzi N
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):771-83. PubMed ID: 8996844
[TBL] [Abstract][Full Text] [Related]
19. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
20. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]